CBA 2018 Annual Conference
Date: October 6, 2018 @ 8:00 am – @ 5:00 pm
Location: Crowne Plaza, Foster City, CA
CBA 2018 Annual Conference
Theme: Building Bridges to Biotech Innovations
Conference Highlight:
- Keynote presentations from Dr. Mien-Chie Hung (VP of MD Anderson Cancer Center), Wei Wang (President, Sinopharm Group) and Dr. Timothy Lu (Associate Professor, MIT)
- New trends of regulatory considerations in both US and China
- Special talk from FDA officer
- Digital Health and Big Data
- Investment and Entrepreneurship
- Expected to attract more than 300 attendees from bioscience and biopharma industries
- Networking opportunities with life science professionals and potential clients
- On-site recruitment (Simcere, 先声药业)
Registration: https://www.eventbrite.com/e/cba-2018-annual-conference-tickets-49057123176
Please use the promo code “cabs5off” to get a $5 off for your ticket.
Conference Ticket Price:
Breakfast, lunch and event reception are included in the ticket.
Ticket types |
Early Bird (by 9/29/2018) |
Regular (9/29/2018 – 10/5/2018) |
On-site (10/6/2018) |
CBA Member |
$35 |
$55 |
$80 |
Non-member |
$55 |
$75 |
$100 |
Student (with .edu email) |
$10 |
$10 |
$30 |
Conference Agenda:
8:00 – 8:30 am |
Registration, Networking, and Exhibitions |
8:30 – 8:35 am |
Welcome and Opening Remarks Mark Chen, Ph.D., CBA president |
8:35 – 8:40 am |
Conference Introduction Thomas Wei, Ph.D., CBA Conference Chair |
Morning Keynote Presentation (Moderators: Mark Chen and Lin Sun-Hoffman) |
|
8:40 – 9:20 am |
Marker-guided targeted therapy, PARP inhibitors, and immune checkpoint therapy Mien-Chie Hung, Ph.D. (Basic Research VP, MD Anderson Cancer Center, The University of Texas) |
9:20 – 10:00 am |
Entrepreneurship in China Wei Wang (Sinopharm Group, President) *Interpreter: Tom Zhang |
10:00 – 10:15 am |
Networking and Exhibitions |
Session I: Drug Regulation (Moderator: Kai Zheng) |
|
10:15 – 10:45 am |
Regulatory considerations in the IND submission of antibody and related products Audrey Jia, Ph.D. (Principal Consultant, DataRevive LLC) |
10:45 am – 11:15 am |
Regulatory consideration for clinical development in product life cycle management Ardelle Ying, Ph.D. (Program Director, Genentech) |
11:15 am – 11:45 am |
Accelerate new drug development: Paradigm shift in the post-ICH regulatory systems in China, and US Dan Zhang, Ph.D. (Chairman and CEO, Fountain Medical Development Ltd) |
Special Talk (Introduced by: Huifang Li) |
|
11:45 am – 12:15 pm |
Career Development for Life – IQ, EQ, and SQ / Career Opportunities in the FDA George Chang, Ph.D.(Senior Pharmacologist, FDA) |
12:15 pm– 12:25pm |
Sponsor Presentation (Eirgenix) |
12:25 – 1:15 pm |
Lunch, Networking and Exhibitions |
1:15 – 1:25 pm |
CBA Scholarship Award |
Afternoon Keynote Presentation (Introduced by: Thomas Wei) |
|
1:25 – 2:05pm |
Engineering Biological Computers for Human Health Applications Timothy Lu, Ph.D. (Associate Professor, MIT) |
Session II: Digital Health and Big Data (Moderator: Michelle Chen) |
|
2:05 – 2:35pm |
Online dermatology transition from dermatologists to artificial intelligence Alexander Börve, MD (Founder & CEO, First Derm) |
2:35 – 3:05pm |
Genomic revolution and blockchain Huijun Zhou, Ph.D. (Co-founder, Doctor Chain) |
3:05 – 3:35pm |
Using Genomic Features to Make Smart Clinical Decisions: the Power of Machine Learning and RNA-seq Jing Huang, Ph.D. (SVP of Bioinformatics and Data Science, Veracyte Inc.) |
3:35 – 3:50pm |
Networking and Exhibitions |
3:50 – 4:50pm |
Investment and Entrepreneurship Panel Discussion (Moderator: Lin Sun-Hoffman) Jo Shen, Ph.D. (Vivo Capital) Keting Chu, Ph.D.(Lyfe Venture) Jimmy Zhang, Ph.D. MBA (Lily Asia Venture) Guoliang Yu, Ph.D. (Global CEO of CBT Pharmaceuticals) |
4:50 – 4:55 pm |
Closing Remarks Thomas Wei, Ph.D., CBA Conference Chair |
5:00 – 7:00 pm |
Evening Reception |
Registration: https://www.eventbrite.com/e/cba-2018-annual-conference-tickets-49057123176
Please use the promo code “cabs5off” to get a $5 off for your ticket.
.